Literature DB >> 19302994

Prevalence of serum antibodies to TORCH among women before pregnancy or in the early period of pregnancy in Beijing.

Zhiyan Li1, Cuiling Yan, Ping Liu, Rong Yan, Zhenru Feng.   

Abstract

BACKGROUND: The primary infection of Toxoplasma gondii (TOX), rubella virus (RV), cytomegalovirus (CMV), or herpes simplex virus (HSV), abbreviated as TORCH, remains a major problem in the pregnant women in China today.
METHODS: We analyzed the performance of a novel chemiluminesent immunoassay (CLIA) for anti-TORCH IgM and IgG detection then analyzed the prevalence of TORCH infection among 4692 women at childbearing age in Beijing, China.
RESULTS: The functional sensitivity of detecting anti-TOX IgM, anti-RV IgM, anti-CMV IgM and anti-HSV (types 1 and 2) IgM were 1.4, 3.2, 1.0 AU/ml and 0.5 index, respectively. The within-assay and the total CVs were both <10%, and recoveries of these assays ranged from 90-110%. High concentration of hemoglobin, lipids and bilirubin in sample did not affect the results. The infective rate of TORCH was 17.2%, with the highest positive rate of anti-HSV IgM. Within anti-TORCH IgG, anti-CMV IgG had the highest infective rate, 92.5%.
CONCLUSIONS: The infective rate of TORCH was fairly high among women before pregnancy or in the early period of pregnancy in Beijing. Entirely new approaches to prevention and treatment of congenital TORCH infection are necessary.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302994     DOI: 10.1016/j.cca.2009.03.027

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  10 in total

1.  Help in the Choice of Automated or Semiautomated Immunoassays for Serological Diagnosis of Toxoplasmosis: Evaluation of Nine Immunoassays by the French National Reference Center for Toxoplasmosis.

Authors:  O Villard; B Cimon; C L'Ollivier; H Fricker-Hidalgo; N Godineau; S Houze; L Paris; H Pelloux; I Villena; E Candolfi
Journal:  J Clin Microbiol       Date:  2016-10-12       Impact factor: 5.948

2.  Prevalence of Serum Antibodies to TORCH Infection in and Around Varanasi, Northern India.

Authors:  M R Sen; B N Shukla; Banerjee Tuhina
Journal:  J Clin Diagn Res       Date:  2012-11

3.  Detection of TORCH pathogens in children with congenital cataracts.

Authors:  Bin Lu; Yabo Yang
Journal:  Exp Ther Med       Date:  2016-05-17       Impact factor: 2.447

Review 4.  Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.

Authors:  Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans
Journal:  Clin Microbiol Rev       Date:  2019-12-11       Impact factor: 26.132

5.  Seasonal influence on TORCH infection and analysis of multi-positive samples with indirect immunofluorescence assay.

Authors:  Lu Chen; Jingrui Liu; Lei Shi; Yang Song; Yujie Song; Yang Gao; Ying Dong; Lin Li; Min Shen; Yanhong Zhai; Zheng Cao
Journal:  J Clin Lab Anal       Date:  2019-01-21       Impact factor: 2.352

6.  TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China.

Authors:  Lin-Chuan Wang; Fang Yan; Jing-Xiong Ruan; Yao Xiao; Yan Yu
Journal:  BMC Pregnancy Childbirth       Date:  2019-12-09       Impact factor: 3.007

7.  Kinetics of IgG antibody to cytomegalovirus (CMV) after birth and seroprevalence of anti-CMV IgG in Chinese children.

Authors:  Jie Chen; Lingqing Hu; Meiling Wu; Tianying Zhong; Yi-Hua Zhou; Yali Hu
Journal:  Virol J       Date:  2012-12-10       Impact factor: 4.099

8.  Cytomegalovirus seroprevalence in pregnant women and association with adverse pregnancy/neonatal outcomes in Jiangsu Province, China.

Authors:  Shu Zhang; Lingqing Hu; Jie Chen; Biyun Xu; Yi-Hua Zhou; Yali Hu
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

9.  The Association Between Previous TORCH Infections and Pregnancy and Neonatal Outcomes in IVF/ICSI-ET: A Retrospective Cohort Study.

Authors:  Yifeng Liu; Yiqing Wu; Feixia Wang; Siwen Wang; Wei Zhao; Lifen Chen; Shijiong Tu; Yuli Qian; Yun Liao; Yun Huang; Runjv Zhang; Gufeng Xu; Dan Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-05       Impact factor: 5.555

10.  The Screening of Rubella Virus, Cytomegalovirus, Hepatitis B Virus, and Toxoplasma gondii Antibodies in Prepregnancy and Reproductive-Age Women in Tabriz, Iran.

Authors:  Edris Nabizadeh; Anahita Ghotaslou; Behnaz Salahi; Reza Ghotaslou
Journal:  Infect Dis Obstet Gynecol       Date:  2022-01-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.